{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:59:44Z","timestamp":1758052784258,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.clinbiochem.2006.01.020","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T08:45:47Z","timestamp":1142325947000},"page":"617-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Eric","family":"Wittersheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Demulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Guns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Melot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Dratwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2006.01.020_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib4","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"341","article-title":"Renal osteodystrophy in adults and children","author":"Goodman","year":"1999"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone level for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib6","first-page":"1019","article-title":"Increased levels of osteoprotegerin in hemodialysis patients","volume":"40","author":"Avbersek-Luznik","year":"2002","journal-title":"J. Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/ajkd.2002.31409","article-title":"Osteoprotegerin and parathyroid hormone as a marker of high turnover osteodystrophy and decreased bone mineralization in hemodialysis patients","volume":"39","author":"Haas","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ndt\/gfh672","article-title":"Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?","volume":"20","author":"Avbersek-Luznik","year":"2005","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/clinchem\/47.4.747","article-title":"ELISA methodology for detection of modified osteoprotegerin in clinical studies","volume":"47","author":"Chen","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000081552","article-title":"Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients","volume":"98","author":"Reichel","year":"2004","journal-title":"Nephron, Clin. Pract."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/clinchem\/36.7.1328","article-title":"Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen","volume":"36","author":"Melkko","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ki.1978.45","article-title":"Skeletal X-ray findings and bone histology in patients on haemodialysis","volume":"13","author":"Ritz","year":"1978","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01480087","article-title":"Bone mineral content during chronic hemodialysis: long term observation by 125-i photonabsorptiometry (author's translation)","volume":"56","author":"Kuhlencordt","year":"1978","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib16","first-page":"2306","article-title":"Serum osteoprotegerin levels in healthy controls and cancer patients","volume":"8","author":"Lipton","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib17","first-page":"3162","article-title":"Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status","volume":"86","author":"Szulc","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(03)00090-5","article-title":"Serum levels of osteoprotegerin increase with age in a healthy adult population","volume":"32","author":"Kudlacek","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men","volume":"13","author":"Khosla","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/eje.0.1500305","article-title":"Circulating levels of receptor activator of nuclear factor-kappaB ligand\/osteoprotegerin\/macrophage-colony stimulating factor in a presumably healthy human population","volume":"150","author":"Trofimov","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib21","first-page":"193","article-title":"Serum osteoprotegrin level is lower in peritoneal dialysis patients than in hemodialysis ones","volume":"49","author":"Grzegorzewska","year":"2004","journal-title":"Rocz. Akad. Med. BiaLymst."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF03347242","article-title":"Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic haemodialysis","volume":"28","author":"Gonnelli","year":"2005","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib23","series-title":"The parathyroids, basic and clinical concepts","first-page":"185","article-title":"Interactions of parathyroid hormone, parathyroid hormone-related protein, and their fragments with conventional receptor sites","author":"Murray","year":"1994"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib24","series-title":"The parathyroids, basic and clinical concepts","first-page":"171","article-title":"Parathyroid hormone and parathyroid hormone-related protein as polyhormones","author":"Mallette","year":"1994"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bone.2004.12.015","article-title":"Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins","volume":"36","author":"Abrahamsen","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00198-004-1699-x","article-title":"Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover","volume":"16","author":"Indridason","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2004.02179.x","article-title":"Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males","volume":"62","author":"Oh","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2265.2005.02221.x","article-title":"The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone","volume":"62","author":"Han","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib29","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1210\/jc.2005-0794","article-title":"Circulating osteoprotegerin (OPG) and receptor activator for NF-kB ligand (RANKL): clinical utility in metabolic bone disease assessment","volume":"90","author":"Rogers","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2006.01.020_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000186151","article-title":"Osteocalcin, iPTH, Alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy","volume":"56","author":"Mazzaferro","year":"1990","journal-title":"Nephron"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912006000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912006000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:23:20Z","timestamp":1757863400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912006000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0009912006000476"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.01.020","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}